Healthcare >> CEO Interviews >> May 28, 2001
WAYNE P. YETTER is Chairman and Chief Executive Officer of SYNAVANT
Inc.Mr. Yetter joined IMS HEALTH as Chief Operating Officer in October
1999, responsible for growing global operations. Prior to joining IMS
HEALTH, he served as President and Chief Executive Officer of Novartis
Pharmaceuticals Corporation, the US division of Novartis AG. In this
position, he successfully completed the merger of the Ciba-Geigy and
Sandoz US pharmaceutical businesses. From 1991 to 1997, Mr. Yetter
oversaw the development and growth of Astra Merck Inc. Under his
leadership first as President and General Manager, then President and
Chief Executive Officer, Prilosec' became the world's leading
pharmaceutical product. In 1977, Mr. Yetter joined Merck & Co., serving
in a variety of product management and marketing positions, including
Vice President, Marketing Operations and Vice President, Far
East/Pacific. From 1970 to 1977, he held sales and product management
positions with the Pfizer Laboratories Division of Pfizer, Inc. Mr.
Yetter earned a BA degree in Biology from Wilkes University in Wilkes-
Barre, Pennsylvania, and an MBA degree from Bryant College in
Smithfield, Rhode Island. He also served as a First Lieutenant with the
Fourth Infantry Division in Vietnam. Mr. Yetter served on the Board of
Directors of the Pharmaceutical Research and Manufacturers Association,
the HealthCare Institute of New Jersey and the National Pharmaceutical
Council. He is a member of the Board of Trustees for the Foundation for
Managed Care Pharmacy; the Board of Directors of Noven Pharmaceuticals
and of Transkaryotic Therapies, Inc. and the SEI Center for Advanced
Studies in Management at the Wharton School. He is a member of the Board
of Trustees of Wilkes University. Profile
perhaps an overview of the company as it is now.
Mr. Yetter: SYNAVANT was created by the spin-off and
